Photo taken from Yüksel Ürün/X
Dec 28, 2023, 17:11
Yüksel Ürün: The crucial role of low-grade AEs in cancer treatment
Yüksel Ürün, Professor at the Department of Medical Oncology, Ankara University School of Medicine, recently posted on X/Twitter:
“New insights from ‘Patient Experience, Adverse Event Reporting, and Clinical Trial Design’ highlight the crucial role of low-grade AEs in cancer treatment. Patients’ daily struggles matter!
Let’s design trials with patient experiences at heart.”
For the article click here.
Source: Yüksel Ürün/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 17:57
Nov 14, 2024, 17:46
Nov 14, 2024, 17:46
Nov 14, 2024, 17:42
Nov 14, 2024, 17:14